New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2012
10:16 EDTINFY, DVA, RIMM, EIX, TEVA, RDS.A, QLGC, OXY, MYGN, KNXA, JNS, SJM, HMA, ELX, CNK, CF, RATEOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Bankrate (RATE) downgraded to Hold from Buy at Canaccord... Bankrate (RATE) downgraded to Sector Perform from Outperform at RBC Capital... CF Industries (CF) downgraded to Neutral from Overweight at Piper Jaffray... Cinemark (CNK) downgraded to Neutral from Overweight at JPMorgan... Emulex (ELX) downgraded to Sell from Neutral at Goldman... Health Management (HMA) downgraded to Sell from Fair Value at CRT Capital... J.M. Smucker (SJM) downgraded to Equal Weight from Overweight at Stephens... Janus Capital (JNS) downgraded to Sell from Neutral at Goldman... Kenexa (KNXA) downgraded to Market Perform from Outperform at JMP Securities... Myriad Genetics (MYGN) downgraded to Neutral from Buy at Mizuho... Occidental Petroleum (OXY) downgraded to Hold from Buy at Deutsche Bank... QLogic (QLGC) downgraded to Sell from Neutral at Goldman... Regal Entertainment (RGC) downgraded to Neutral from Overweight at JPMorgan... Royal Dutch Shell (RDS.A) downgraded to Hold from Buy at Deutsche Bank... Teva (TEVA) downgraded to Neutral from Buy at UBS... Edison International (EIX) downgraded to Market Perform from Outperform at Bernstein... Research in Motion (RIMM) downgraded to Sell from Hold at Canaccord... DreamWorks (DWA) downgraded to Sell from Hold at Stifel Nicolaus... Infosys (INFY) downgraded to Neutral from Outperform at Cowen.
News For A;TEVA;EIX;RIMM;DVA;INFY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
10:02 EDTEIXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:11 EDTTEVATeva reported great Q3 results, says BMO Capital
Subscribe for More Information
09:06 EDTTEVATeva says assessing M&A opportunities of all sizes
08:49 EDTTEVATeva says may pursue generic businesses in emerging markets
Says not ruling out "transformational" transactions. Says open to specialty assets in U.S., Europe.
08:40 EDTTEVATeva says $5.00-$5.10 FY14 EPS guidance is for exclusive Copaxone scenario
Subscribe for More Information
07:06 EDTTEVATeva board authorizes increase in share repurchase program to $3B
The Company announced today that, as authorized by the Board of Directors, it will increase its share repurchase program by $1.7 billion to $3 billion. The program has no time limitations. The Company intends to begin purchasing shares promptly.
07:05 EDTTEVATeva raises FY14 EPS view to $5.00-$5.10 from $4.90-$5.10
Subscribe for More Information
07:05 EDTTEVATeva reports Q3 EPS $1.32, consensus $1.23
Subscribe for More Information
06:48 EDTEIXEdison International downgraded to Neutral from Buy at UBS
UBS downgraded Edison International to Neutral due to valuation. Price target raised to $65 from $60.
October 29, 2014
16:12 EDTAAgilent reports Q3 EPS 3c, one estimate 3c
Subscribe for More Information
October 28, 2014
16:21 EDTEIXEdison International raises FY14 core EPS view to $4.25-$4.35, consensus $3.87
16:20 EDTEIXEdison International reports Q3 core EPS $1.52, consensus $1.33
Reports Q3 revenue $4.36B, consensus $3.9B.
October 27, 2014
18:38 EDTAS&P announces changes to the S&P MidCap 400 and S&P SmallCap 600 indices
Subscribe for More Information
07:22 EDTTEVAAmerican College of Chest Physicians to hold a conference
Subscribe for More Information
October 22, 2014
20:03 EDTDVADaVita Kidney Care finalizes DOJ Settlement
DaVita Kidney Care, a division of DaVita HealthCare Partners announced it has finalized its comprehensive settlement with the U.S. Department of Justice, or DOJ, and certain other federal agencies regarding allegations of improperly structured joint ventures with certain physician partners. As announced in February, DaVita Kidney Care will be subject to a Corporate Integrity Agreement and an independent monitor to oversee certain future joint ventures. The agreement also includes a repayment to the government and a provision requiring executive certification of quarterly and annual compliance reports.
06:42 EDTDVADaVita to acquire CSHP
Subscribe for More Information
October 20, 2014
07:10 EDTAAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
06:28 EDTTEVAAllergan price target raised to $210 from $190 at Citigroup
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use